Search for an ETF or holding
Regencell Bioscience Holdings L (RGC) is a Hong Kong company in the healthcare sector, listed on NASDAQ. Market capitalization of 11.7 billion USD (large-cap).
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.